Suspension of ulipristal acetate for uterine fibroids during ongoing EMA’s review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!

Author:

Rozenberg SergeORCID,Revercez Perrine,Fastrez Maxime,Vandromme Jean,Bucella Dario

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference14 articles.

1. Indications and hemoglobin thresholds for red blood cell transfusion in the adult;Carson,2019

2. Rozenberg S Medical or surgical management of fibroids? An internet survey of gynecologists’ views;Pazzaglia;Maturitas,2017

3. The use of selective progestin receptor modulators (SPRMs) and more specifically ulipristal acetate in the practice of gynaecology;Rozenberg;Aust N Z J Obstet Gynaecol,2017

4. EMA, 2020: https://www.ema.europa.eu/en/documents/referral/ulipristal-acetate-5mg-medicinal-products-article-31-referral-review-started_en.pdf.

5. Ulipristal acetate versus placebo for fibroid treatment before surgery;Donnez;N Engl J Med,2012

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Drug-induced Liver Injury from Hormonal and Non-hormonal Therapies: Insights from a Large Case Series;Journal of Clinical and Experimental Hepatology;2024-05

2. Contemporary approaches in the management of uterine leiomyomas;European Journal of Obstetrics & Gynecology and Reproductive Biology;2023-08

3. Care for uterine fibroids: another casualty of the COVID pandemic;BJOG: An International Journal of Obstetrics & Gynaecology;2022-10-23

4. Hysteroscopic myomectomy: The guidelines of the International Society for Gynecologic Endoscopy (ISGE);European Journal of Obstetrics & Gynecology and Reproductive Biology;2022-01

5. Management of symptomatic uterine fibroids after ulipristal acetate suspension and identification of high risk patients for surgery at 6-months of follow-up;Gynecological Endocrinology;2021-05-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3